| Study of SRP-1003 in Participants With Type 1 Myotonic Dystrophy (NCT06138743) | Sarepta Therapeutics, Inc. | 2024-03-04 |
| Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors (NCT06391918) | GenVivo, Inc. | 2024-03-04 |
| The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases (NCT06285279) | Nanjing University School of Medicine | 2024-03-04 |
| Hydrogen's Feasibility and Safety as a Therapy in ECPR (NCT05574296) | Boston Children's Hospital | 2024-03-04 |
| A Study to Assess Mass Balance, Pharmacokinetics, Metabolism, and Excretion of Emraclidine in Healthy Adult Male Participants (NCT06301971) | Cerevel Therapeutics, LLC | 2024-03-04 |
| Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya (NCT06165614) | UNC Lineberger Comprehensive Cancer Center | 2024-03-04 |
| Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin Lymphoma (NCT06088654) | Innate Pharma | 2024-03-04 |
| A Food Effect Study of SPH5030 Tablets. (NCT06372223) | Shanghai Pharmaceuticals Holding Co., Ltd | 2024-03-04 |
| Phase 1 Study of DHP2302R1 and DHP2302R2 in Healthy Adult Volunteers (NCT06318845) | Daehwa Pharmaceutical Co., Ltd. | 2024-03-04 |
| Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer (NCT06300489) | Zhejiang Cancer Hospital | 2024-03-03 |
| Ultrasonic Treatment of Food Addiction (NCT06249711) | University of Utah | 2024-03-03 |
| Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies (NCT05887167) | Joshua Sasine, MD, PhD | 2024-03-02 |
| A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fasting Conditions in Healthy Adult Volunteers (NCT06289920) | Boryung Pharmaceutical Co., Ltd | 2024-03-02 |
| Safety and Efficacy of Loco-regional B7H3 IL-7Ra CAR T Cell in DIPG (NCT06221553) | Chulalongkorn University | 2024-03-01 |
| Efficacy of Skin Cooling in Reducing Pain Associated With Non-invasive Treatments of Neurofibromatosis Type 1 Cutaneous Neurofibromas (NCT06132165) | Massachusetts General Hospital | 2024-03-01 |
| Allogeneic CD30 Chimeric Antigen Receptor Epstein-Barr Virus-Specific T Lymphocytes in Relapsed or Refractory CD30-Positive Lymphomas (NCT04952584) | Baylor College of Medicine | 2024-03-01 |
| A Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-DNL343 Following a Single Oral Dose in Healthy Male Participants (NCT06281158) | Denali Therapeutics Inc. | 2024-03-01 |
| A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors (NCT06223841) | SUNHO（China）BioPharmaceutical CO., Ltd. | 2024-03-01 |
| Micro-encapsulated Hepatocyte Intraperitoneal Transplantation in Liver Failure Adults (NCT05727722) | RenJi Hospital | 2024-03-01 |
| Safety, Pharmacokinetics and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab in Participants With Solid Tumors in Chinese Participants (NCT05644626) | BeiGene | 2024-03-01 |
| IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver Disease (NCT06324396) | Children's Mercy Hospital Kansas City | 2024-03-01 |
| Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease (NCT06117423) | University Medical Center Groningen | 2024-03-01 |
| A Lithium-containing Mouthwash Prevention and Treatment of Oral Mucositis and Dysgeusia in Patients Undergoing Radiotherapy (NCT06251050) | West China Hospital | 2024-03-01 |
| Allogeneic Immunotherapy of Hematological Malignancies Using Regulatory T-cell Selective Depletion (NCT06180499) | Assistance Publique - Hôpitaux de Paris | 2024-03-01 |
| Study of CG0070 After Transurethral Resection in Patients With IR NMIBC (NCT06253845) | H. Lee Moffitt Cancer Center and Research Institute | 2024-03-01 |
| NAPO - Novel Approach for Oligospermia (NCT06300229) | Martin Blomberg Jensen | 2024-03-01 |
| Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to Calcineurin Inhibitors (NCT06279494) | Peking University People's Hospital | 2024-03-01 |
| A Study of V330 in Healthy Younger (18 to 49 Years Inclusive) and Healthy Older (60 to 79 Years Inclusive) Participants (V330-001) (NCT06630117) | Merck Sharp & Dohme LLC | 2024-03-01 |
| Randomized, Double-blind, Placebo-controlled Study of RSS0393 Ointment in Healthy and Psoriatic Subjects (NCT06308393) | Jiangsu HengRui Medicine Co., Ltd. | 2024-03-01 |
| Comparison Between Bupivacaine-Dexmedetomidine Versus Bupivacaine-Dexamethasone in Pericapsular Nerve Group (PENG) Block (NCT06294665) | Ain Shams University | 2024-03-01 |
| Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid Tumors (NCT05952687) | St. Jude Children's Research Hospital | 2024-03-01 |
| "Comparing Methotrexate Usage Techniques to Prevent Proliferative Vitreoretinopaty After Retinal Detachment Vitrectomy" (NCT06289205) | University of Health Sciences Lahore | 2024-03-01 |
| A Study to Assess the Availability of Oral Primaquine and Its Inert Metabolite, Carboxyprimaquine, in the Body (NCT05938608) | University of Oxford | 2024-03-01 |
| HUC-MSC for Treatment of High-risk HPV Infection (NCT06610773) | Shanghai East Hospital | 2024-03-01 |
| A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions (NCT06266988) | Viatris Inc. | 2024-03-01 |
| Benefits of a Cannabidiolic Acid Topical Cream for the Treatment of Restless Leg Syndrome (NCT06570941) | Synthonics Inc | 2024-03-01 |
| A Phase I Study of LTC004 Combin With FC in Patients With Advanced/Metastatic Malignancies Tumor (NCT06277804) | Letolab | 2024-03-01 |
| RE002 T Cell Injection for the Treatment of KRAS G12D Mutated Solid Tumors (NCT06546150) | Henan Cancer Hospital | 2024-03-01 |
| A Single-center Clinical Study to Evaluate the Safety and Efficacy of Autologous Bone Marrow-derived DCs(CellgramDC-WT1) and Immune Checkpoint Inhibitors in Patients With Metastatic Pancreatic Cancer Who Have Failed First-line or More Standard Chemotherapy (NCT06172634) | Soonchunhyang University Hospital | 2024-03-01 |
| Study of HS-20105 for Injection in Patients With Advanced Solid Tumors. (NCT06144723) | Hansoh BioMedical R&D Company | 2024-03-01 |
| Evaluate the Efficacy and Safety of EN001 in Patients With Duchenne Muscular Dystrophy (NCT06328725) | ENCell | 2024-03-01 |
| Efficacy of Oxygen-ozone Therapy and Cervical Rehabilitation (NCT07504432) | University of Catanzaro | 2024-03-01 |
| A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3 (NCT06273553) | RinuaGene Biotechnology Co., Ltd. | 2024-03-01 |
| Assessment of Therapeutic Effect of Rectal Vs. Intravenous Paracetamol in The Treatment of Patent Ductus Arteriosus (PDA) in Neonates (NCT06256211) | Soha mahmoud Hussien mahdy | 2024-03-01 |
| A Study to Evaluate ENT-01 for the Treatment of Parkinson's Disease Dementia (NCT03938922) | Enterin Inc. | 2024-03-01 |
| Personalized Neoantigen Peptide Vaccines for Solid Tumors (NCT07002203) | Seqker Biosciences, Inc. | 2024-03-01 |
| The Phase I Study of HS-10509 in Chinese Adult Subjects (NCT06301074) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2024-03-01 |
| Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus (NCT06297408) | Shanghai Ming Ju Biotechnology Co., Ltd. | 2024-03-01 |
| Pharmacology of Mupirocin in Nasal Application in Healthy Volunteers: Monocentric Study (NCT06368856) | Centre Hospitalier Universitaire de Saint Etienne | 2024-02-29 |
| Subcutaneous Semaglutide in Systemic Scleroderma (NCT06149260) | Second Xiangya Hospital of Central South University | 2024-02-29 |
| A Study of VRG50635 in Healthy Volunteers (NCT06286475) | Verge Genomics | 2024-02-29 |
| Safety and Efficacy of KDSTEM Inj. in Patients With Chronic Kidney Disease (NCT06071143) | EHL Bio Co., Ltd. | 2024-02-29 |
| Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC) (NCT06085729) | M.D. Anderson Cancer Center | 2024-02-29 |
| A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers (NCT06120504) | Seagen, a wholly owned subsidiary of Pfizer | 2024-02-29 |
| A Clinical Study of AK0610 (NCT06996704) | Shanghai Ark Biopharmaceutical Co., Ltd. | 2024-02-29 |
| Gene Therapy for ACM Due to a PKP2 Pathogenic Variant (NCT06109181) | Lexeo Therapeutics | 2024-02-29 |
| Platelet Rich Plasma Combined With Human Umbilical Cord Mesenchymal Stem Cells for Stage 3 and 4 Stress Injury (NCT06302582) | Liaocheng People's Hospital | 2024-02-29 |
| PAS-004 in Patients With Advanced Solid Tumors (NCT06299839) | Pasithea Therapeutics Corp. | 2024-02-29 |
| Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure：Phase I/II (NCT06195189) | Sichuan University | 2024-02-29 |
| Efficacy and Safety of Baricitinib in the Post-intracerebral Hemorrhage Pulmonary Injury (NCT06548802) | Tianjin Medical University General Hospital | 2024-02-29 |
| Effectiveness of Topical Magnetite Zinc Oxide Composite Nanoparticles in the Management of Oral Potentially Malignant Lesions (NCT06271564) | Ain Shams University | 2024-02-29 |
| C-TIL051 in Non-Small Cell Lung Cancer (NCT05676749) | AbelZeta Inc. | 2024-02-29 |
| A Study of BL-M07D1 in Patients With HER2-expressing Recurrent or Metastatic Gynecologic Malignancies (NCT06131450) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-02-29 |
| A Study to Investigate the Effect on QTcF of Baxdrostat Compared With Placebo, Using Moxifloxacin as a Positive Control, in Healthy Participants (NCT06194032) | AstraZeneca | 2024-02-29 |
| A Study of LY3537982 in Chinese Participants With Advanced Solid Tumors (NCT06235983) | Eli Lilly and Company | 2024-02-29 |
| A Study of HRS9531 in Participants With Impaired Kidney Function and Healthy Subjects (NCT06246175) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2024-02-28 |
| Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors (MK-1200-002) (NCT06242691) | Merck Sharp & Dohme LLC | 2024-02-28 |
| A Mass Balance Study of [14C]-Nanatinostat and Relative Bioavailability Study of Nanatinostat in Patients With Advanced Cancers (NCT06302140) | Viracta Therapeutics, Inc. | 2024-02-28 |
| A Trial to Assess the Bioequivalence of Generic Tiotropium Bromide Inhalation Powder and Reference Product in Healthy Adult Participants Under Fasting Conditions (Pilot) (NCT06326671) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-02-28 |
| A Study to Investigate the Effect of Urine Acid-base Disequilibrium on the Pharmacokinetics of Captopril (NCT06292091) | Seoul National University Hospital | 2024-02-28 |
| A Clinical Study of SCTC21C in Participants With CD38+ Hematologic Malignancies (NCT06252298) | Sinocelltech Ltd. | 2024-02-28 |
| A Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma (NCT06126237) | Keymed Biosciences Co.Ltd | 2024-02-28 |
| Fruquintinib in Combination With Sintilimab and CAPEOX as First-line Treatment for G/GEJ Cancer (NCT06329973) | Henan Cancer Hospital | 2024-02-28 |
| A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome (Australia Only) (NCT06112275) | Encoded Therapeutics | 2024-02-28 |
| A Study to Assess Safety and Tolerability of GS1-144 in Healthy Volunteers (NCT06204250) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2024-02-27 |
| Safety and Pharmacokinetics Study of Multiple Ascending Doses and Food Effect of LV232 Capsules (NCT06279533) | Vigonvita Life Sciences | 2024-02-27 |
| A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors (NCT06208124) | Immuneering Corporation | 2024-02-27 |
| Empagliflozin 10 mg Tablets Relative to Jardiance 10 mg (NCT06232239) | Bio-innova Co., Ltd | 2024-02-27 |
| A Study to Test How Either a Capsule or a Tablet With NDec (Decitabine and Tetrahydrouridine) Works in the Body of Healthy People (NCT06291285) | Novo Nordisk A/S | 2024-02-27 |
| A Trial Investigating Lu AF28996 in Healthy Adult Participants (NCT06277609) | H. Lundbeck A/S | 2024-02-27 |
| A Study to Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma (NCT06163898) | Celgene | 2024-02-27 |
| Effect of Vitamin D Injection on Hypertrophic Scars and Keloids (NCT06301178) | Mostafa Bahaa | 2024-02-27 |
| A Study to Learn How Different Forms of Study Medicine Tafamidis Are Taken Up Into The Blood in Healthy Adults (NCT06273839) | Pfizer | 2024-02-27 |
| Adoptive T-cell Therapy for Resistant Viral Infections After Allogeneic HSCT (NCT05075837) | Istituto Giannina Gaslini | 2024-02-27 |
| A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream (NCT06213831) | Incyte Corporation | 2024-02-27 |
| A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight (NCT06289504) | Novo Nordisk A/S | 2024-02-27 |
| Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer (NCT05996107) | University of Michigan Rogel Cancer Center | 2024-02-27 |
| A Study of HC006 in Subjects With Advanced Solid Tumors (NCT06304571) | HC Biopharma Inc. | 2024-02-27 |
| Pharmacokinetics and Bioequivalence of Doxylamine+Pyridoxine and Diclectin Under Fed Conditions in Healthy Volunteers (NCT06342778) | Valenta Pharm JSC | 2024-02-27 |
| To Compare the Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability Between SHR-3167 Injection and Glargine Insulin in Healthy Subjects (NCT07588906) | Jiangsu HengRui Medicine Co., Ltd. | 2024-02-26 |
| A Dose Response Investigation of Docosahexaenoic Acid (DHA) (NCT06294067) | University of Toronto | 2024-02-26 |
| Treating Patients With Traumatic Chondral Lesions With Autologous Bone Marrow Cells Derived Engineered Tissues - Engineered Osteochondral Tissue (NCT06400862) | Chinese University of Hong Kong | 2024-02-26 |
| A First-in-human, Single-ascending-dose Study of IBI3002 in Healthy Participants and Mild to Moderate Asthmatics (NCT06213844) | Innovent Biologics (Suzhou) Co. Ltd. | 2024-02-26 |
| AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC) (NCT06245915) | Arsenal Biosciences, Inc. | 2024-02-26 |
| A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged Fasting (NCT06288412) | Novo Nordisk A/S | 2024-02-26 |
| First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer (NCT06239467) | OnKure, Inc. | 2024-02-26 |
| Phase 1 Study for IPG11406 in Health Volunteer (NCT06255834) | Nanjing Immunophage Biotech Co., Ltd | 2024-02-24 |
| A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body Weight (NCT06207877) | Novo Nordisk A/S | 2024-02-23 |
| SNV1521 in Participants With Advanced Solid Tumors (NCT06220864) | Synnovation Therapeutics, Inc. | 2024-02-23 |
| TR128 in Patients With Advanced Solid Tumors (NCT05751356) | Tarapeutics Science Inc. | 2024-02-23 |